anonymous
Guest
anonymous
Guest
Galderma just laid off a bunch of its sales force today. We have far fewer scripts in the Derm BU and far more head count. This can't last too much longer-Eucrisa is a losing proposition, and Cibinqo is a total dog. Good luck getting on board another company when word is out we're not a performance based organization, we were out 2 years with Covid, and we barely work. I'm looking for another position within Pfizer to continue this gravy train.